May 19, 2016
Special demand for novel hepatitis C treatments pushed up earnings of major drug distributor Suzuken in the year ended March, with its sales in the pharmaceutical wholesaling business exceeding Medipal Holdings’ by a whisker 5 billion yen to rank second,...read more